Work

Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Year: 2017

Type: article

Source: Circulation

DOI: 10.1161/circulationaha.117.029095

Authors: Erin A. Bohula, Stephen D. Wiviott, Robert P. Giugliano, Michael A. Blazing, Jeong-Gun Park, Sabina A. Murphy, Jennifer A. White, Francois Mach, Frans Van de Werf, Anthony J. Dalby, Harvey D. White, Andrew M. Tershakovec, Christopher P. Cannon, Eugene Braunwald

Institutions: Brigham and Women's Hospital, Harvard University, Thrombolysis in Myocardial Infarction Study Group, Duke Clinical Research Institute, University Hospital of Geneva, KU Leuven, Milpark Hospital, Auckland City Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, Alnylam Pharmaceuticals, Regeneron Pharmaceuticals, Medicines Company, Kowa Company, Daiichi-Sankyo

OpenAlex ID: W2757304856

FWCI: 9.99

Cites: 24

Cited by: 143

Related to: 10